Over-The-Counter (OTC) Drug Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Germany,UK,Japan,China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 173 SKU: IRTNTR75281

Over-the-counter Drug Market Size 2023-2027

The Global Over-the-counter Drug Market size is projected to reach a value of USD 58.54 billion at a CAGR of 6.53% between 2022 and 2027. Market growth in the drug market is driven by several factors, including the introduction of new products, increasing prevalence of diseases prompting higher usage of over-the-counter (OTC) drugs, and supportive regulatory environments. As pharmaceutical companies continue to innovate and launch new drugs, the market expands to accommodate these offerings. Furthermore, the rising incidence of various diseases contributes to a higher demand for OTC drugs, further fueling market growth. Additionally, favorable regulations that support the availability and accessibility of OTC drugs also play a significant role in driving market expansion. This combination of factors is reshaping the landscape of the global drug market, offering opportunities for growth and innovation.

 Market Overview

To learn more about this report, View Report Sample

Market Segmentation

This market report extensively covers market segmentation by Route Of Administration (oral, topical, parenteral, and others ), Distribution Channel (offline and online ), and Geography (North America, Europe, Asia, and the rest of the world (ROW)).

By Route of Administration

The market share growth by the oral segment will be significant during the forecast period. The most practical, economical, and common method of drug administration is oral administration. Oral drugs are drugs that are taken orally, either as tablets, capsules, or liquids. The small intestine is normally the major site of drug absorption, and the amount of drug absorbed across the intestinal epithelium affects drug bioavailability. This is the most preferred route due to its advantages such as non-invasiveness, patient compliance, and convenience of drug delivery. 

Get a glance at the market contribution of various segments View the PDF Sample

By Distribution Channel 

Online drug stores had the smallest market share within the global market in 2022. A digital pharmacy operates as an Internet-based company selling medications, encompassing both legitimate and illegitimate outlets, predominantly in countries like India. These digital pharmacies include independent online-only platforms and those formed through partnerships among pharmacies. Current trends indicate a surge in e-commerce activities, including online shopping for prescription and non-prescription drugs, notably drug medications.

These digital pharmacies provide a convenient and accessible way for individuals to obtain drugs without the need to physically visit a brick-and-mortar store. The emergence of online drug store distribution channels has offered consumers the convenience of easily ordering online drugs using their mobile phones or computers.

The availability of medications for sale is primarily due to their classification as non-prescription drugs. Regulators meticulously evaluate these drugs based on their safety profile and the ease of self-administration, which enables their sale without a prescription. The medications for sale have widespread availability contributing to consumer convenience and ease of access for managing various health conditions. Additionally, many medications for sale address common health concerns such as pain relief, cold symptoms, allergies, and minor ailments, making them easily accessible to consumers for self-care purposes.

By Region

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The regional market is expected to grow during the forecast period due to several factors such as population growth and increasing disposable income. Moreover, the increase in self-medication in the region and its availability, as well as the cost-effectiveness drugs, are expected to further drive the growth of the market during the forecast period. The presence of multiple medicines providers in the region is one of the major growth drivers of the market in North America. The increasing prevalence of chronic diseases in the region is also boosting the growth of the market. 

Market Dynamics

The market is driven by B2C spend and consumer healthcare spending, with hospitals playing a crucial role. The market faces challenges such as Patent expiry concerns and the impact of Pharma giants. Concerns over Substance abuse and Incorrect diagnosis highlight the need for caution. Conditions like Kidney failure, Memory loss, and Heart problems underscore the importance of proper usage. Patients experiencing Fatal cases, Nausea, or Acidity should consult a Pharmacist or Doctor. Self-medication associations play a role in promoting responsible use. Understanding symptoms like Fever and Diarrhea can help in selecting appropriate medications.

Key Market Driver

The rising prevalence of diseases and pharmaceutical use is notably driving the drug market growth. The global prevalence of acute and chronic diseases including cardiovascular, neurological, orthopedic, and respiratory diseases is increasing significantly. More than 550,000 people in the United States are diagnosed with heart failure each year. According to the Centers for Disease Control and Prevention (CDC), approximately 790,000 people in the United States have a heart attack each year, of which approximately 580,000 have a first heart attack and 210,000 have a recurrent heart attack. 

Risk factors such as diabetes, hypertension, tobacco use, and obesity are indeed increasing the prevalence of chronic cardiac, neurological, and orthopedic diseases. These conditions can lead to heart problems, fatal cases, fever, acidity, and nausea, highlighting the importance of early detection and management.  With the rise of chronic diseases, the use of medicines has become more widespread as patients seek effective and convenient treatment options for their chronic diseases. For example, aspirin is widely used to prevent heart attacks, strokes, and other cardiovascular diseases in patients with a history of heart disease or who are at high risk of developing heart disease. Similarly, ibuprofen and acetaminophen are commonly used to reduce pain and inflammation associated with conditions such as arthritis, chronic back pain, and headaches. Therefore, increasing chronic diseases across the globe will lead to increased demand for pharmaceuticals, which will boost the growth of the market during the forecast period. 

Significant Market Trends

The increasing geriatric population and increasing healthcare expenses is a key trend influencing the drug market growth. The elderly population around the world is increasing year by year. Older people may prefer medicines for symptom relief. The escalating prevalence of chronic diseases alongside a rise in disposable income is propelling healthcare expenditures upward. This surge in healthcare spending presents substantial growth prospects for companies providing Emerging Healthcare Trends. Consequently, heightened healthcare expenditures are facilitating improved access to advanced drug therapies and quality healthcare facilities, presenting a positive trajectory for the global market in the forecast period, in alignment with emerging healthcare trends. Hence the burgeoning healthcare spending represents an imminent emerging healthcare trend in the market.

Major Market Challenges

Price sensitivity issues associated are challenging the drug market growth. A major challenge for the global market is price sensitivity. Customers are very price sensitive as medicines are seen as less necessary than prescription drugs. As a result, they are more likely to opt for cheaper generic drugs or abandon treatment altogether. This puts pressure on manufacturers to keep prices low, negatively impacting profit margins and limiting investment in R&D. Another issue related to price sensitivity is the need for competitive pricing. As more players enter the market, companies must price their products competitively to remain relevant. This often leads to lower prices and lower profit margins. This phenomenon may also contribute to the lack of differentiation between similar products, which may adversely affect the growth of the market. When competition drives prices down, companies are forced to cut costs, which may adversely affect product quality and efficacy. Overall, price sensitivity is having a significant impact on the drug market, limiting its potential for growth and innovation during the forecast period. 

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Market Customer Landscape

Key Market Players

companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers different types such as Abocal, Arinac, and many more. It is also involved in the manufacturing of branded generic pharmaceuticals.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Achelios Therapeutics Inc.
  • AstraZeneca Plc
  • Bayer AG
  • BioGaia AB
  • Boehringer Ingelheim International GmbH
  • Bukwang Pharmaceutical Co. Ltd.
  • Chr Hansen Holding AS
  • Cipla Ltd.
  • CVS Health Corp.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Novartis AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis opportunities from 2017 to 2027. 

  • Route of Administration Outlook 
    • Oral
    • Topical
    • Parenteral
    • Others
  • Distribution Channel Outlook
    • Offline
    • Online
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Rest of World (ROW)

Market Analyst Overview

The market is influenced by various factors such as product sales trends, health system accessibilities, and GDP. With rising concerns over drug abuse and the need for effective report attributes to track trends, the market is evolving. Gastrointestinal products, including antacids and laxatives, are in demand due to the increasing cases of digestive cancer. The retail pharmacy segment is expanding, aided by trends like medical tourism. Skin-related conditions drive the need for OTC medicines. Patient awareness programs and compliance with drugs and cosmetics acts are crucial for promoting safe self-medications. The market's growth is supported by the easy availability and affordability of these drugs.

Furthermore, the market is shaped by various factors, including a modeling approach that considers historical data and current trends. Conditions like digestive cancer, heartburn, and constipation drive the demand for Over-the-Counter Medicines. Medical practices and adherence to Drugs and Cosmetics Act guidelines influence the market landscape. Insights from peer-reviewed journals and real-world clinical scenarios inform market strategies. The global OTC market continues to expand, offering diverse opportunities for growth and innovation in meeting consumer healthcare needs.

Market Scope

Report Coverage

Details

Page number

173

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.53%

Market growth 2023-2027

USD 58.54 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

5.37

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Germany, UK, Japan, and China

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Ltd., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.

Market dynamics

Market Trends and Analysis, Market Forecasting, Market growth and forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global over-the-counter drug market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global over-the-counter drug market 2017 - 2021 ($ billion)
    • 4.2 Route of Administration Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Route of Administration Segment 2017 - 2021 ($ billion)
    • 4.3 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Route of Administration

    • 6.1 Market segments
      • Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
    • 6.2 Comparison by Route of Administration
      • Exhibit 32: Chart on Comparison by Route of Administration
      • Exhibit 33: Data Table on Comparison by Route of Administration
    • 6.3 Oral - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
    • 6.4 Topical - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
    • 6.5 Parenteral - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
    • 6.6 Others - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Route of Administration
      • Exhibit 50: Market opportunity by Route of Administration ($ billion)
      • Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 54: Chart on Comparison by Distribution Channel
      • Exhibit 55: Data Table on Comparison by Distribution Channel
    • 7.3 Offline - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
    • 7.4 Online - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Distribution Channel
      • Exhibit 64: Market opportunity by Distribution Channel ($ billion)
      • Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 Japan - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 115: Abbott Laboratories - Overview
              • Exhibit 116: Abbott Laboratories - Business segments
              • Exhibit 117: Abbott Laboratories - Key news
              • Exhibit 118: Abbott Laboratories - Key offerings
              • Exhibit 119: Abbott Laboratories - Segment focus
            • 12.4 Achelios Therapeutics Inc.
              • Exhibit 120: Achelios Therapeutics Inc. - Overview
              • Exhibit 121: Achelios Therapeutics Inc. - Product / Service
              • Exhibit 122: Achelios Therapeutics Inc. - Key offerings
            • 12.5 AstraZeneca Plc
              • Exhibit 123: AstraZeneca Plc - Overview
              • Exhibit 124: AstraZeneca Plc - Product / Service
              • Exhibit 125: AstraZeneca Plc - Key news
              • Exhibit 126: AstraZeneca Plc - Key offerings
            • 12.6 Bayer AG
              • Exhibit 127: Bayer AG - Overview
              • Exhibit 128: Bayer AG - Business segments
              • Exhibit 129: Bayer AG - Key news
              • Exhibit 130: Bayer AG - Key offerings
              • Exhibit 131: Bayer AG - Segment focus
            • 12.7 BioGaia AB
              • Exhibit 132: BioGaia AB - Overview
              • Exhibit 133: BioGaia AB - Business segments
              • Exhibit 134: BioGaia AB - Key news
              • Exhibit 135: BioGaia AB - Key offerings
              • Exhibit 136: BioGaia AB - Segment focus
            • 12.8 Boehringer Ingelheim International GmbH
              • Exhibit 137: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 138: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 139: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus
            • 12.9 Bukwang Pharmaceutical Co. Ltd.
              • Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview
              • Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings
            • 12.10 Chr Hansen Holding AS
              • Exhibit 145: Chr Hansen Holding AS - Overview
              • Exhibit 146: Chr Hansen Holding AS - Business segments
              • Exhibit 147: Chr Hansen Holding AS - Key news
              • Exhibit 148: Chr Hansen Holding AS - Key offerings
              • Exhibit 149: Chr Hansen Holding AS - Segment focus
            • 12.11 CVS Health Corp.
              • Exhibit 150: CVS Health Corp. - Overview
              • Exhibit 151: CVS Health Corp. - Business segments
              • Exhibit 152: CVS Health Corp. - Key news
              • Exhibit 153: CVS Health Corp. - Key offerings
              • Exhibit 154: CVS Health Corp. - Segment focus
            • 12.12 GlaxoSmithKline Plc
              • Exhibit 155: GlaxoSmithKline Plc - Overview
              • Exhibit 156: GlaxoSmithKline Plc - Business segments
              • Exhibit 157: GlaxoSmithKline Plc - Key news
              • Exhibit 158: GlaxoSmithKline Plc - Key offerings
              • Exhibit 159: GlaxoSmithKline Plc - Segment focus
            • 12.13 Johnson and Johnson Services Inc.
              • Exhibit 160: Johnson and Johnson Services Inc. - Overview
              • Exhibit 161: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 162: Johnson and Johnson Services Inc. - Key news
              • Exhibit 163: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 164: Johnson and Johnson Services Inc. - Segment focus
            • 12.14 Novartis AG
              • Exhibit 165: Novartis AG - Overview
              • Exhibit 166: Novartis AG - Business segments
              • Exhibit 167: Novartis AG - Key offerings
              • Exhibit 168: Novartis AG - Segment focus
            • 12.15 Pfizer Inc.
              • Exhibit 169: Pfizer Inc. - Overview
              • Exhibit 170: Pfizer Inc. - Product / Service
              • Exhibit 171: Pfizer Inc. - Key news
              • Exhibit 172: Pfizer Inc. - Key offerings
            • 12.16 Reckitt Benckiser Group Plc
              • Exhibit 173: Reckitt Benckiser Group Plc - Overview
              • Exhibit 174: Reckitt Benckiser Group Plc - Business segments
              • Exhibit 175: Reckitt Benckiser Group Plc - Key offerings
              • Exhibit 176: Reckitt Benckiser Group Plc - Segment focus
            • 12.17 Sanofi SA
              • Exhibit 177: Sanofi SA - Overview
              • Exhibit 178: Sanofi SA - Business segments
              • Exhibit 179: Sanofi SA - Key news
              • Exhibit 180: Sanofi SA - Key offerings
              • Exhibit 181: Sanofi SA - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 182: Inclusions checklist
                • Exhibit 183: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 184: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 185: Research methodology
                • Exhibit 186: Validation techniques employed for market sizing
                • Exhibit 187: Information sources
              • 13.5 List of abbreviations
                • Exhibit 188: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              over-the-counter drug market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis